These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1292974

  • 21. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 22. Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: Chemical quantities in serum and urine.
    Mosekilde L, Christensen MS, Melsen F, Sørensen NS.
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):743-50. PubMed ID: 580520
    [Abstract] [Full Text] [Related]

  • 23. Fine adjustments in thyroxine replacement and its effect on bone metabolism.
    Campbell J, Day P, Diamond T.
    Thyroid; 1996 Apr; 6(2):75-8. PubMed ID: 8733875
    [Abstract] [Full Text] [Related]

  • 24. [Management of subclinical hyperthyroidism].
    Galofré JC.
    Rev Med Univ Navarra; 2007 Apr; 51(1):18-22. PubMed ID: 17555116
    [Abstract] [Full Text] [Related]

  • 25. [Disorders of bone metabolism in hyperthyroidism].
    Langer B.
    Praxis; 1967 Jul 27; 56(30):1018-34. PubMed ID: 4180979
    [No Abstract] [Full Text] [Related]

  • 26. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism.
    Lee MS, Kim SY, Lee MC, Cho BY, Lee HK, Koh CS, Min HK.
    J Clin Endocrinol Metab; 1990 Mar 27; 70(3):766-70. PubMed ID: 2307730
    [Abstract] [Full Text] [Related]

  • 27. Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
    Faber J, Overgaard K, Jarløv AE, Christiansen C.
    Thyroidology; 1994 Apr 27; 6(1):27-32. PubMed ID: 7536445
    [Abstract] [Full Text] [Related]

  • 28. Serum cytokines and bone metabolism in patients with thyroid dysfunction.
    Sekeroglu MR, Altun ZB, Algün E, Dülger H, Noyan T, Balaharoglu R, Oztürk M.
    Adv Ther; 2006 Apr 27; 23(3):475-80. PubMed ID: 16912030
    [Abstract] [Full Text] [Related]

  • 29. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G, Karter Y, Aydin S, Uzun H.
    Chin J Physiol; 2003 Dec 31; 46(4):181-6. PubMed ID: 15074839
    [Abstract] [Full Text] [Related]

  • 30. [Serum osteocalcin and bone turnover in hyperthyroidism].
    León Sanz M, Hawkins F, Larrodera L, Sarabia F, Schuller A.
    Rev Clin Esp; 1990 Mar 31; 186(4):155-8. PubMed ID: 2367716
    [Abstract] [Full Text] [Related]

  • 31. Thyroid function and bone turnover.
    Bijlsma JW, Duursma SA, Roelofs JM, der Kinderen PJ.
    Acta Endocrinol (Copenh); 1983 Sep 31; 104(1):42-9. PubMed ID: 6688695
    [Abstract] [Full Text] [Related]

  • 32. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ.
    Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602
    [Abstract] [Full Text] [Related]

  • 33. Bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in thyrotoxicosis.
    Broulik PD, Stĕpán JJ, Límanová Z, Pacovský V.
    Endocrinol Exp; 1985 Sep 16; 19(3):165-9. PubMed ID: 3876205
    [Abstract] [Full Text] [Related]

  • 34. [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].
    Esedova AE, Gadzhieva MM, Ferzilaeva RA.
    Klin Lab Diagn; 2002 Mar 16; (3):13-6. PubMed ID: 11980136
    [Abstract] [Full Text] [Related]

  • 35. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism.
    Ross DS, Ardisson LJ, Nussbaum SR, Meskell MJ.
    J Clin Endocrinol Metab; 1991 Feb 16; 72(2):507-9. PubMed ID: 1991818
    [Abstract] [Full Text] [Related]

  • 36. Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment.
    Stĕpán JJ, Límanová Z.
    Bone Miner; 1992 Jun 16; 17(3):377-88. PubMed ID: 1623331
    [Abstract] [Full Text] [Related]

  • 37. [Beta-2-microglobulin in hyperthyroidism].
    Foscolo G, Roiter I, De Menis E, Legovini P, Conte N.
    Minerva Endocrinol; 1992 Jun 16; 17(1):1-5. PubMed ID: 1495449
    [Abstract] [Full Text] [Related]

  • 38. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy.
    Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P.
    Thyroid; 1996 Jun 16; 6(3):161-8. PubMed ID: 8837321
    [Abstract] [Full Text] [Related]

  • 39. Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism.
    Sabuncu T, Aksoy N, Arikan E, Ugur B, Tasan E, Hatemi H.
    Endocr Res; 2001 Jun 16; 27(1-2):203-13. PubMed ID: 11428712
    [Abstract] [Full Text] [Related]

  • 40. Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.
    Heemstra KA, van der Deure WM, Peeters RP, Hamdy NA, Stokkel MP, Corssmit EP, Romijn JA, Visser TJ, Smit JW.
    Eur J Endocrinol; 2008 Jul 16; 159(1):69-76. PubMed ID: 18390987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.